Main Menu

TCR² Therapeutics Inc.

(NASDAQ GS: TCRR)

Rigrodsky Law, P.A. is investigating TCR² Therapeutics Inc. (“TCR²”) regarding possible breaches of fiduciary duties and other violations of law related to TCR²’s agreement to be acquired by Adaptimmune Therapeutics plc.      

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 06/14/2024


* Indicates a required field.

Back to Page